• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏移植术后死亡的移植前危险因素:亨利·蒙多医院的经验

Pretransplantation risk factors for death after heart transplantation: the Henri Mondor experience.

作者信息

Kirsch M, Baufreton C, Naftel D C, Benvenuti C, Loisance D Y

机构信息

Department of Thoracic and Cardiovascular Surgery, Hôpital Henri Mondor, Créteil, France.

出版信息

J Heart Lung Transplant. 1998 Mar;17(3):268-77.

PMID:9563603
Abstract

BACKGROUND AND METHODS

Risk factors for death after primary heart transplantation were identified by analyzing our total experience with 234 patients who underwent transplantation at our institution from May 28, 1979, to May 27, 1996.

RESULTS

There were 205 male and 29 female patients. Mean recipient age was 48.5+/-10.9 years (standard deviation). Recipient diagnosis included ischemic cardiomyopathy in 103 (44%), idiopathic cardiomyopathy in 98 (42%), valvular heart disease in 17 (7%), congenital heart disease in 4 (2%), and other diagnoses in 12 (5%) patients. Donor age was 32+/-10.2 years. Graft ischemic time was 138.1+/-51.8 minutes. The operative mortality rate was 23.5%. Actuarial survival estimates for all patients at 1, 5, and 10 years were 62%, 50%, and 44%, respectively. The three most common causes of death (both early and late) after primary heart transplantation were infection (27.4%), acute rejection (18.9%), and early graft failure (17.9%). Multivariate logistic regression analysis identified older recipient age (p = 0.007), higher preoperative pulmonary vascular resistance (p = 0.01), recipient preoperative hepatic insufficiency (p = 0.001), and gender mismatch (p = 0.02) as independent predictors of early death (within 3 months of the procedure). Multivariate proportional hazard regression analysis revealed that recipient idiopathic cardiomyopathy (p = 0.02) and recipient preoperative liver failure (p = 0.01) were independent risk factors for late death (after 3 months).

CONCLUSION

These results underscore the importance of adequate recipient selection and recipient/donor matching for short- and long-term survival after primary heart transplantation.

摘要

背景与方法

通过分析1979年5月28日至1996年5月27日在我院接受心脏移植的234例患者的全部经验,确定了心脏原位移植术后死亡的危险因素。

结果

男性患者205例,女性患者29例。受者平均年龄为48.5±10.9岁(标准差)。受者诊断包括缺血性心肌病103例(44%)、特发性心肌病98例(42%)、瓣膜性心脏病17例(7%)、先天性心脏病4例(2%)以及其他诊断12例(5%)。供者年龄为32±10.2岁。移植物缺血时间为138.1±51.8分钟。手术死亡率为23.5%。所有患者1年、5年和10年的精算生存率分别为62%、50%和44%。心脏原位移植术后(早期和晚期)最常见的三种死亡原因是感染(27.4%)、急性排斥反应(18.9%)和早期移植物功能衰竭(17.9%)。多因素逻辑回归分析确定,受者年龄较大(p = 0.007)、术前肺血管阻力较高(p = 0.01)、受者术前肝功能不全(p = 0.001)以及性别不匹配(p = 0.02)是早期死亡(术后3个月内)的独立预测因素。多因素比例风险回归分析显示,受者特发性心肌病(p = 0.02)和受者术前肝功能衰竭(p = 0.01)是晚期死亡(术后3个月后)的独立危险因素。

结论

这些结果强调了在心脏原位移植术后短期和长期生存中,进行充分的受者选择以及受者/供者匹配的重要性。

相似文献

1
Pretransplantation risk factors for death after heart transplantation: the Henri Mondor experience.心脏移植术后死亡的移植前危险因素:亨利·蒙多医院的经验
J Heart Lung Transplant. 1998 Mar;17(3):268-77.
2
Pretransplantation risk factors for death after heart transplantation: a multiinstitutional study. The Transplant Cardiologists Research Database Group.心脏移植术后死亡的移植前危险因素:一项多机构研究。移植心脏病学家研究数据库组。
J Heart Lung Transplant. 1993 Jul-Aug;12(4):549-62.
3
[Heart transplantation 1985-1995: 10 years experience at the "Angelo De Gasperis" center. Improvement of results by progress in operative criteria].[心脏移植1985 - 1995:“安杰洛·德加斯佩里斯”中心的10年经验。通过手术标准的进展改善结果]
G Ital Cardiol. 1997 Jan;27(1):3-18.
4
Donor-recipient size matching in pediatric heart transplantation: a word of caution about small grafts.小儿心脏移植中供体与受体的大小匹配:关于小移植物的一点警示
J Heart Lung Transplant. 1996 Feb;15(2):190-5.
5
Heart transplantation 1985-1998: 13-years experience at Angelo De Gasperis Cardio-Thoracic Department-Milan.1985 - 1998年心脏移植:米兰安杰洛·德加斯佩里斯心胸外科13年经验
Clin Transpl. 1998:315-25.
6
Three-year survival rates for all consecutive heart-only and lung-only transplants performed in Eurotransplant, 1997-1999.1997年至1999年在欧洲移植组织进行的所有连续单纯心脏移植和单纯肺移植的三年生存率。
Clin Transpl. 2003:89-100.
7
Effect of older donor age on risk for mortality after heart transplantation.供体年龄较大对心脏移植后死亡风险的影响。
Ann Thorac Surg. 2004 Sep;78(3):890-9. doi: 10.1016/j.athoracsur.2004.02.016.
8
Outcomes in patients older than 60 years of age undergoing orthotopic heart transplantation: an analysis of the UNOS database.60岁以上患者原位心脏移植的结果:对器官共享联合网络(UNOS)数据库的分析
J Heart Lung Transplant. 2008 Feb;27(2):184-91. doi: 10.1016/j.healun.2007.11.566.
9
Long-term results of combined heart-lung transplantation: the Stanford experience.心肺联合移植的长期结果:斯坦福大学的经验
J Heart Lung Transplant. 1994 Nov-Dec;13(6):940-9.
10
Matching the heart donor and heart transplant recipient. Clues for successful expansion of the donor pool: a multivariable, multiinstitutional report. The Cardiac Transplant Research Database Group.心脏供体与心脏移植受者的匹配。扩大供体库成功的线索:一项多变量、多机构报告。心脏移植研究数据库组
J Heart Lung Transplant. 1994 May-Jun;13(3):353-64; discussion 364-5.

引用本文的文献

1
Choosing wisely: incorporating appropriate donor-recipient size matching in heart transplantation.明智选择:在心脏移植中纳入合适的供受者体型匹配。
Heart Fail Rev. 2023 Jul;28(4):967-975. doi: 10.1007/s10741-023-10299-1. Epub 2023 Feb 23.
2
Influence of Sex-Mismatch on Prognosis After Heart Transplantation.性别不匹配对心脏移植术后预后的影响。
Front Cardiovasc Med. 2021 Mar 25;8:617062. doi: 10.3389/fcvm.2021.617062. eCollection 2021.
3
Increased serum Wisteria floribunda agglutinin positive Mac-2 binding protein (Mac-2 binding protein glycosylation isomer) in chronic heart failure: a pilot study.
慢性心力衰竭患者血清紫藤凝集素阳性Mac-2结合蛋白(Mac-2结合蛋白糖基化异构体)升高:一项初步研究。
Heart Vessels. 2018 Apr;33(4):385-392. doi: 10.1007/s00380-017-1071-7. Epub 2017 Nov 2.
4
Mortality, rehospitalization, and post-transplant complications in gender-mismatched heart transplant recipients.性别不匹配的心脏移植受者的死亡率、再次住院率及移植后并发症
Heart Lung. 2017 Jul-Aug;46(4):265-272. doi: 10.1016/j.hrtlng.2017.04.004. Epub 2017 May 10.
5
First-year clinical outcomes in gender-mismatched heart transplant recipients.性别错配心脏移植受者的 1 年临床结局。
J Cardiovasc Nurs. 2012 Nov-Dec;27(6):519-27. doi: 10.1097/JCN.0b013e31822ce6c9.
6
Predictors of rehospitalization time during the first year after heart transplant.心脏移植后第一年再次住院时间的预测因素。
Heart Lung. 2008 Sep-Oct;37(5):344-55. doi: 10.1016/j.hrtlng.2007.10.007.
7
Effect of receiving a heart transplant: analysis of a national cohort entered on to a waiting list, stratified by heart failure severity. Comparative Outcome and Clinical Profiles in Transplantation (COCPIT) Study Group.接受心脏移植的效果:对进入等候名单的全国队列进行分析,按心力衰竭严重程度分层。移植比较结果与临床概况(COCPIT)研究组。
BMJ. 2000 Sep 2;321(7260):540-5. doi: 10.1136/bmj.321.7260.540.